Inhibition of joint structural damage with rituximab is not dependant on clinical response in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors (REFLEX study). Keystone, E., Emery, P., Peterfy, C. G., Tak, P. P., Cohen, S. B., Genovese, M. C., Williams, S., Totoritis, M. C., Cravets, M. W., Shaw, T. WILEY-LISS. 2006: S542–S543

View details for Web of Science ID 000240877203026